4
Changes in Ownership
ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-22-051551
Chief Executive Officer acquired 40,624 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Anzalone Christopher Richard · Chief Executive Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-09-27 | Exercise or conversion : show line 1 in the form | −39,082 | $30.77 | $1,202,553 | 3,469,856 | D |
| 2022-09-27 | Exercise or conversion : show line 2 in the form | −1,542 | $31.21 | $48,126 | 3,468,314 | D |
Loading xslF345X03/doc4.xml…